Novartis Strikes $1.7 Billion Drug Target Deal With UK Biotech

Novartis AG will pay UK biotech Relation Therapeutics Ltd. as much as $1.7 billion to help find drug targets to treat allergic diseases.

By Ashleigh Furlong · Bloomberg

Novartis AG will pay UK biotech Relation Therapeutics Ltd. as much as $1.7 billion to help find drug targets to treat allergic diseases.